ArticleScience advances2026
Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicity.
Yvonne T Kschonsak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it